3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting researcher attention due to initial information suggesting different physiological characteristics. Current studies demonstrate that 3-HPC may exhibit distinct impacts on the brain system, potentially contributing to some of the unexpected reactions associate